lageplan_ppt_2018_v1

SCARLETRED is an international dermatology startup aiming on to generate novel products for highly demanded applications in the digital analysis and therapeutic treatment of skin diseases.

COMPANY PRODUCT AND R&D PORTFOLIO

SCARLETRED®Vision: The patented mobile medical device system enables objective skin documentation and analysis in (pre-)clinical trials and in skin care industry.

– Superoxide Dismutase: The anti-inflammatory acting biologics rhSOD is under clinical development to treat acute and non healing wounds in the orphan disease Epidermolysis bullosa (Butterfly Children).

SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1
8th Floor
1030 Vienna
Austria
Building: MQM3

Harald Schnidar, PhD, MBA

+43 (0) 664 410 94 04